Riken Vitamin Co. Ltd. | Income Statement
Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
85,419
85,603
88,072
87,181
89,515
89,888
Cost of Goods Sold (COGS) incl. D&A
60,727
61,298
62,388
60,064
62,652
63,786
Gross Income
24,692
24,305
25,684
27,117
26,863
26,102
SG&A Expense
19,665
19,654
19,655
20,055
20,598
21,048
EBIT
5,027
4,651
6,029
7,062
6,265
5,054
Unusual Expense
327
505
962
312
562
129
Non Operating Income/Expense
394
570
330
66
3,266
1,556
Interest Expense
441
504
593
704
739
756
Pretax Income
5,334
5,251
6,106
6,148
8,277
6,044
Income Tax
1,718
1,452
1,957
1,792
2,654
2,070
Consolidated Net Income
3,616
3,799
4,149
4,356
5,622
3,973
Net Income
3,590
3,795
4,129
4,330
5,639
3,949
Net Income After Extraordinaries
3,590
3,795
4,129
4,330
5,639
3,949
Net Income Available to Common
3,590
3,795
4,129
4,330
5,640
3,949
EPS (Basic)
162.36
171.63
187.42
270.03
345.31
240.92
Basic Shares Outstanding
22
22
22
16
16
16
EPS (Diluted)
162.36
171.63
187.42
269.68
345.25
240.92
Diluted Shares Outstanding
22
22
22
16
16
16
EBITDA
8,434
8,553
9,417
10,558
9,904
8,969
Non-Operating Interest Income
27
29
38
36
48
62
Minority Interest Expense
26
4
20
26
17
24
About Riken Vitamin Co.
View Profile
